News
Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...
Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Most patients with type 1 diabetes using an inhaled insulin increased their daily insulin dose by more than 4 U from baseline ...
Adolescent hyperglycemia and worsening insulin resistance are associated with an increased risk for worsening structural and functional cardiac damage.
Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a study published today in the Journal of ...
Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has gained attention in various research studies ...
While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...
4d
Lose It! on MSNHow to Exercise While on a GLP-1 Medication, According to ExpertsShould you exercise differently if you’re on a GLP-1 weight loss drug such as Ozempic or Wegovy? Here’s what to know about which physical activities best support your health goals.
News Evidence That GLP-1 Drugs Achieve Weight Loss Primarily by Reducing Fat Mass More Than Muscle. Diabetes and obesity have become pressing health issues worldwide. Glucagon-lik ...
Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol addiction. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results